11월 18일 16:06

Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New

Debiopharm , a Swiss biopharmaceutical company aiming to cure cancer and infectious diseases, is pleased to announce today the launch of the new IDEAL Japan initiative. This program was initiated to provide financial support to Japanese academic r...

2024년 9월 24일 09:03

Debiopharm Recognizes Groundbreaking Japanese Cancer Research During the 83rd Annual Meeting of the Japanese Cancer Association

Debiopharm , a Swiss-based, global biopharmaceutical company, aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases, today announced the recognition of the two recipients of the 2024 JCA-Mauvernay Award, marking th...

2024년 9월 13일 14:30

ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors

ITM Isotope Technologies Munich SE (ITM) , a leading radiopharmaceutical biotech company and Debiopharm , a Swiss-based, global biopharmaceutical company, aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases, toda...

 전체 기업